Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Atopic dermatitis: role of oxatomide].

A Taieb1

  • 1Service de Dermatologie, Hôpital des Enfants, Bordeaux.

Annales De Dermatologie Et De Venereologie
|January 1, 1990
PubMed
Summary

Oxatomide, a calcium channel blocker, shows promising results for treating atopic dermatitis. While more research is needed, studies indicate good tolerance with minimal side effects like sleepiness and weight gain in children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Centred Care in AD Was Discussed at a Meeting in Doha Organized by the International Society of Atopic Dermatitis.

JEADV clinical practice·2026
Same author

How to integrate atopic dermatitis in the management of skin neglected tropical diseases in Sub-Saharan Africa?

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

A rare case of grave's disease after SARS-CoV-2 vaccine: is it an adjuvant effect?

European review for medical and pharmacological sciences·2022
Same author

Regional differences between Japan and the Netherlands in atopic dermatitis patient-reported outcome measures: which interpretation?

The British journal of dermatology·2021
Same author

Management of albinism: French guidelines for diagnosis and care.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Area of Science:

  • Pharmacology
  • Immunology
  • Dermatology

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition.
  • Oxatomide is an antiallergic agent with calcium channel blocking properties.

Purpose of the Study:

  • To review the efficacy and safety of oxatomide in treating atopic dermatitis.
  • To explore potential immunologic mechanisms of hypersensitivity reactions to oxatomide.

Main Methods:

  • Review of published studies on oxatomide treatment for atopic dermatitis.
  • Analysis of patient data from controlled and open-label studies.

Main Results:

  • Encouraging therapeutic benefits reported in multiple studies.
  • Excellent tolerance observed in 200 evaluated patients.
  • Minimal adverse events, including transient sleepiness and weight gain in a few children.

Conclusions:

  • Oxatomide demonstrates potential as a treatment for atopic dermatitis.
  • Further research with larger patient cohorts is warranted to fully establish its therapeutic benefit.
  • Oxatomide exhibits a favorable safety profile in patients with atopic dermatitis.

Related Experiment Videos